Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Dysbiosis of the gut microbiota and colorectal cancer: the key target of molecular pathological epidemiology.

Kosumi K, Mima K, Baba H, Ogino S.

J Lab Precis Med. 2018 Sep;3. pii: 76. doi: 10.21037/jlpm.2018.09.05. Epub 2018 Sep 25. No abstract available.

2.

Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells.

Hamada T, Nowak JA, Masugi Y, Drew DA, Song M, Cao Y, Kosumi K, Mima K, Twombly TS, Liu L, Shi Y, da Silva A, Gu M, Li W, Nosho K, Keum N, Giannakis M, Meyerhardt JA, Wu K, Wang M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

J Natl Cancer Inst. 2018 Oct 11. doi: 10.1093/jnci/djy137. [Epub ahead of print]

PMID:
30312431
3.

The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.

Kosumi K, Hamada T, Koh H, Borowsky J, Bullman S, Twombly TS, Nevo D, Masugi Y, Liu L, da Silva A, Chen Y, Du C, Gu M, Li C, Li W, Liu H, Shi Y, Mima K, Song M, Nosho K, Nowak JA, Nishihara R, Baba H, Zhang X, Wu K, Wang M, Huttenhower C, Garrett WS, Meyerson ML, Lennerz JK, Giannakis M, Chan AT, Meyerhardt JA, Fuchs CS, Ogino S.

Am J Pathol. 2018 Dec;188(12):2839-2852. doi: 10.1016/j.ajpath.2018.08.015. Epub 2018 Sep 20.

PMID:
30243655
4.

The impact of preoperative anaemia and anaemic subtype on patient outcome in colorectal cancer.

Tokunaga R, Nakagawa S, Miyamoto Y, Ohuchi M, Izumi D, Kosumi K, Taki K, Higashi T, Miyata T, Yoshida N, Baba H.

Colorectal Dis. 2018 Sep 19. doi: 10.1111/codi.14425. [Epub ahead of print]

PMID:
30230148
5.

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.

PMID:
30228205
6.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Hamada T, Liu L, Nowak JA, Mima K, Cao Y, Ng K, Twombly TS, Song M, Jung S, Dou R, Masugi Y, Kosumi K, Shi Y, da Silva A, Gu M, Li W, Keum N, Wu K, Nosho K, Inamura K, Meyerhardt JA, Nevo D, Wang M, Giannakis M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

Eur J Cancer. 2018 Nov;103:98-107. doi: 10.1016/j.ejca.2018.07.130. Epub 2018 Sep 13.

PMID:
30219720
7.

Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.

Ohuchi M, Sakamoto Y, Tokunaga R, Kiyozumi Y, Nakamura K, Izumi D, Kosumi K, Harada K, Kurashige J, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Shono T, Naoe H, Sasaki Y, Baba H.

Oncol Lett. 2018 Oct;16(4):5275-5281. doi: 10.3892/ol.2018.9240. Epub 2018 Jul 31.

8.

Percutaneous transluminal plasty: a novel approach for refractory anastomotic stricture after esophagectomy.

Yoshida N, Akiyama T, Kinoshita K, Nagai Y, Baba Y, Ishimoto T, Harada K, Tokunaga R, Kosumi K, Baba H.

Esophagus. 2018 Oct;15(4):301-303. doi: 10.1007/s10388-018-0635-7. Epub 2018 Aug 9.

PMID:
30090963
9.

Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study.

Yoshida N, Kosumi K, Tokunaga R, Baba Y, Nagai Y, Miyamoto Y, Iwagami S, Iwatsuki M, Hiyoshi Y, Ishimoto T, Eto K, Imamura Y, Watanabe M, Baba H.

Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002971. [Epub ahead of print]

PMID:
29995687
10.

TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.

Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, Morikawa T, Inamura K, Shukla SA, Wu CJ, Garraway LA, Zhang X, Wu K, Meyerhardt JA, Chan AT, Glickman JN, Rodig SJ, Freeman GJ, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Oncoimmunology. 2018 Mar 19;7(7):e1442999. doi: 10.1080/2162402X.2018.1442999. eCollection 2018.

PMID:
29900052
11.

Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.

Liu L, Tabung FK, Zhang X, Nowak JA, Qian ZR, Hamada T, Nevo D, Bullman S, Mima K, Kosumi K, da Silva A, Song M, Cao Y, Twombly TS, Shi Y, Liu H, Gu M, Koh H, Li W, Du C, Chen Y, Li C, Li W, Mehta RS, Wu K, Wang M, Kostic AD, Giannakis M, Garrett WS, Hutthenhower C, Chan AT, Fuchs CS, Nishihara R, Ogino S, Giovannucci EL.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1622-1631.e3. doi: 10.1016/j.cgh.2018.04.030. Epub 2018 Apr 24.

PMID:
29702299
12.

Pyloroplasty may reduce weight loss 1 year after esophagectomy.

Harada K, Yoshida N, Baba Y, Nakamura K, Kosumi K, Ishimoto T, Iwatsuki M, Miyamoto Y, Sakamoto Y, Ajani JA, Watanabe M, Baba H.

Dis Esophagus. 2018 Mar 1;31(3). doi: 10.1093/dote/dox127.

PMID:
29579257
13.

Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer.

Kosumi K, Yoshida N, Okadome K, Eto T, Kuroda D, Ohuchi M, Kiyozumi Y, Nakamura K, Izumi D, Tokunaga R, Harada K, Mima K, Sawayama H, Ishimoto T, Iwatsuki M, Baba Y, Miyamoto Y, Watanabe M, Baba H.

Dis Esophagus. 2018 Jun 1;31(6). doi: 10.1093/dote/dox153.

PMID:
29444214
14.

Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.

Gu M, Nishihara R, Chen Y, Li W, Shi Y, Masugi Y, Hamada T, Kosumi K, Liu L, da Silva A, Nowak JA, Twombly T, Du C, Koh H, Li W, Meyerhardt JA, Wolpin BM, Giannakis M, Aguirre AJ, Bass AJ, Drew DA, Chan AT, Fuchs CS, Qian ZR, Ogino S.

Oncotarget. 2017 Sep 18;8(50):87379-87389. doi: 10.18632/oncotarget.20972. eCollection 2017 Oct 20.

15.

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.

Masugi Y, Nishihara R, Hamada T, Song M, da Silva A, Kosumi K, Gu M, Shi Y, Li W, Liu L, Nevo D, Inamura K, Cao Y, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, Hodi FS, Freeman GJ, Rodig SJ, Fuchs CS, Qian ZR, Nowak JA, Ogino S.

Cancer Immunol Res. 2017 Nov;5(11):1046-1055. doi: 10.1158/2326-6066.CIR-17-0122. Epub 2017 Oct 16.

16.

Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index.

Shi Y, Qian ZR, Zhang S, Li W, Masugi Y, Li T, Chan JA, Yang J, Da Silva A, Gu M, Liu L, Hamada T, Kosumi K, Dutton T, Brais LK, Nishihara R, Fuchs CS, Ogino S, Kulke MH.

Pancreas. 2017 Nov/Dec;46(10):1347-1353. doi: 10.1097/MPA.0000000000000944.

17.

The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study.

Miyata T, Yamashita YI, Higashi T, Taki K, Izumi D, Kosumi K, Tokunaga R, Nakagawa S, Okabe H, Imai K, Hashimoto D, Chikamoto A, Baba H.

World J Surg. 2018 Apr;42(4):1085-1091. doi: 10.1007/s00268-017-4214-1.

PMID:
28887635
18.

Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment.

Kosumi K, Baba Y, Yamashita K, Ishimoto T, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Harada K, Shigaki H, Kurashige J, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Baba H.

Dis Esophagus. 2017 Dec 1;30(12):1-9. doi: 10.1093/dote/dox092.

PMID:
28881886
19.

Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

Liu L, Nishihara R, Qian ZR, Tabung FK, Nevo D, Zhang X, Song M, Cao Y, Mima K, Masugi Y, Shi Y, da Silva A, Twombly T, Gu M, Li W, Hamada T, Kosumi K, Inamura K, Nowak JA, Drew DA, Lochhead P, Nosho K, Wu K, Wang M, Garrett WS, Chan AT, Fuchs CS, Giovannucci EL, Ogino S.

Gastroenterology. 2017 Dec;153(6):1517-1530.e14. doi: 10.1053/j.gastro.2017.08.045. Epub 2017 Sep 1.

20.

LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review.

Yamamura K, Kosumi K, Baba Y, Harada K, Gao F, Zhang X, Zhou L, Kitano Y, Arima K, Kaida T, Takeyama H, Higashi T, Imai K, Hashimoto D, Chikamoto A, Tan X, Baba H.

Surg Today. 2017 Dec;47(12):1450-1459. doi: 10.1007/s00595-017-1539-1. Epub 2017 May 23. Review.

PMID:
28536860
21.

Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.

Hanyuda A, Cao Y, Hamada T, Nowak JA, Qian ZR, Masugi Y, da Silva A, Liu L, Kosumi K, Soong TR, Jhun I, Wu K, Zhang X, Song M, Meyerhardt JA, Chan AT, Fuchs CS, Giovannucci EL, Ogino S, Nishihara R.

Eur J Epidemiol. 2017 May;32(5):393-407. doi: 10.1007/s10654-017-0254-y. Epub 2017 May 16.

22.

Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.

Hamada T, Cao Y, Qian ZR, Masugi Y, Nowak JA, Yang J, Song M, Mima K, Kosumi K, Liu L, Shi Y, da Silva A, Gu M, Li W, Keum N, Zhang X, Wu K, Meyerhardt JA, Giovannucci EL, Giannakis M, Rodig SJ, Freeman GJ, Nevo D, Wang M, Chan AT, Fuchs CS, Nishihara R, Ogino S.

J Clin Oncol. 2017 Jun 1;35(16):1836-1844. doi: 10.1200/JCO.2016.70.7547. Epub 2017 Apr 13.

23.

Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.

Kosumi K, Masugi Y, Yang J, Qian ZR, Kim SA, Li W, Shi Y, da Silva A, Hamada T, Liu L, Gu M, Twombly TS, Cao Y, Barbie DA, Nosho K, Baba H, Garrett WS, Meyerhardt JA, Giovannucci EL, Chan AT, Fuchs CS, Ogino S, Nishihara R.

Oncoimmunology. 2017 Jan 31;6(3):e1284720. doi: 10.1080/2162402X.2017.1284720. eCollection 2017.

24.

Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.

Keum N, Yuan C, Nishihara R, Zoltick E, Hamada T, Martinez Fernandez A, Zhang X, Hanyuda A, Liu L, Kosumi K, Nowak JA, Jhun I, Soong TR, Morikawa T, Tabung FK, Qian ZR, Fuchs CS, Meyerhardt JA, Chan AT, Ng K, Ogino S, Giovannucci EL, Wu K.

Int J Cancer. 2017 Jun 15;140(12):2648-2656. doi: 10.1002/ijc.30683. Epub 2017 Mar 28.

25.

Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.

Tokunaga R, Sakamoto Y, Nakagawa S, Izumi D, Kosumi K, Taki K, Higashi T, Miyata T, Miyamoto Y, Yoshida N, Baba H.

Int J Clin Oncol. 2017 Aug;22(4):740-748. doi: 10.1007/s10147-017-1102-5. Epub 2017 Feb 17.

PMID:
28213742
26.

Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer.

Yoshida N, Harada K, Baba Y, Kosumi K, Iwatsuki M, Kinoshita K, Nakamura K, Sakamoto Y, Miyamoto Y, Karashima R, Mima K, Sawayama H, Ohuchi M, Chikamoto A, Imamura Y, Watanabe M, Baba H.

Langenbecks Arch Surg. 2017 Mar;402(2):333-341. doi: 10.1007/s00423-017-1553-1. Epub 2017 Jan 30.

PMID:
28138759
27.

Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue.

Mehta RS, Nishihara R, Cao Y, Song M, Mima K, Qian ZR, Nowak JA, Kosumi K, Hamada T, Masugi Y, Bullman S, Drew DA, Kostic AD, Fung TT, Garrett WS, Huttenhower C, Wu K, Meyerhardt JA, Zhang X, Willett WC, Giovannucci EL, Fuchs CS, Chan AT, Ogino S.

JAMA Oncol. 2017 Jul 1;3(7):921-927. doi: 10.1001/jamaoncol.2016.6374.

28.

Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.

Nakamura K, Yoshida N, Baba Y, Kosumi K, Uchihara T, Kiyozumi Y, Ohuchi M, Ishimoto T, Iwatsuki M, Sakamoto Y, Watanabe M, Baba H.

Int J Clin Oncol. 2017 Jun;22(3):469-475. doi: 10.1007/s10147-017-1090-5. Epub 2017 Jan 17.

PMID:
28097441
29.

Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.

Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, Li W, Hamada T, Kosumi K, Hanyuda A, Liu L, Kostic AD, Giannakis M, Bullman S, Brennan CA, Milner DA, Baba H, Garraway LA, Meyerhardt JA, Garrett WS, Huttenhower C, Meyerson M, Giovannucci EL, Fuchs CS, Nishihara R, Ogino S.

Clin Transl Gastroenterol. 2016 Nov 3;7(11):e200. doi: 10.1038/ctg.2016.53.

30.

Retroileal colorectal anastomosis after extended left colectomy: application for laparoscopic surgery.

Sakamoto Y, Tokunaga R, Miyamoto Y, Ohuchi M, Nakamura K, Kosumi K, Harada K, Shigaki H, Kurashige J, Iwatsuki M, Baba Y, Yoshida N, Baba H.

Surg Today. 2016 Dec;46(12):1476-1478. Epub 2016 Feb 18.

PMID:
26892331
31.

CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection.

Tokunaga R, Sakamoto Y, Nakagawa S, Ohuchi M, Izumi D, Kosumi K, Taki K, Higashi T, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.

Int J Colorectal Dis. 2017 Jan;32(1):99-106. doi: 10.1007/s00384-016-2668-5. Epub 2016 Oct 10.

PMID:
27726014
32.

Cancer-related multiple brain infarctions caused by Trousseau syndrome in a patient with metastatic colon cancer: a case report.

Akiyama T, Miyamoto Y, Sakamoto Y, Tokunaga R, Kosumi K, Shigaki H, Kurashige J, Iwatsuki M, Baba Y, Yoshida N, Baba H.

Surg Case Rep. 2016 Dec;2(1):91. doi: 10.1186/s40792-016-0217-7. Epub 2016 Sep 5.

33.

Effect of Esophagus Position on Surgical Difficulty and Postoperative Morbidities After Thoracoscopic Esophagectomy.

Yoshida N, Baba Y, Shigaki H, Shiraishi S, Harada K, Watanabe M, Iwatsuki M, Kurashige J, Sakamoto Y, Miyamoto Y, Ishimoto T, Kosumi K, Tokunaga R, Yamashita Y, Baba H.

Semin Thorac Cardiovasc Surg. 2016 Spring;28(1):172-9. doi: 10.1053/j.semtcvs.2015.12.002. Epub 2015 Dec 18.

PMID:
27568157
34.

Estimation of Physiologic Ability and Surgical Stress (E-PASS) versus modified E-PASS for prediction of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer.

Kitano Y, Iwatsuki M, Kurashige J, Kuroda D, Kosumi K, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Haga Y, Baba H.

Int J Clin Oncol. 2017 Feb;22(1):80-87. doi: 10.1007/s10147-016-1028-3. Epub 2016 Aug 12.

PMID:
27518251
35.

Transnasal inner drainage: an option for managing anastomotic leakage after esophagectomy.

Kosumi K, Baba Y, Ozaki N, Akiyama T, Harada K, Shigaki H, Imamura Y, Iwatsuki M, Yoshida N, Watanabe M, Baba H.

Langenbecks Arch Surg. 2016 Sep;401(6):903-8. doi: 10.1007/s00423-016-1489-x. Epub 2016 Aug 11.

PMID:
27516076
36.

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.

Nakamura K, Baba Y, Kosumi K, Harada K, Shigaki H, Miyake K, Kiyozumi Y, Ohuchi M, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Nakao M, Baba H.

Oncotarget. 2016 Sep 6;7(36):57821-57831. doi: 10.18632/oncotarget.11067.

37.

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.

Harada K, Baba Y, Shigaki H, Ishimoto T, Miyake K, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J, Iwatsuki M, Miyamoto Y, Sakamoto Y, Yoshida N, Watanabe M, Baba H.

BMC Cancer. 2016 Jul 7;16:400. doi: 10.1186/s12885-016-2422-y. Review.

38.

Early gastric cancer metastasizing to the rectum, possibly via a hematogenous route: a case report and review of literature.

Uemura N, Kurashige J, Kosumi K, Iwatsuki M, Yamashita K, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Honda Y, Mikami Y, Baba H.

Surg Case Rep. 2016 Dec;2(1):58. doi: 10.1186/s40792-016-0180-3. Epub 2016 Jun 7.

39.

Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.

Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Sakamoto Y, Miyamoto Y, Kurashige J, Kosumi K, Tokunaga R, Watanabe M, Baba H.

Int J Clin Oncol. 2016 Dec;21(6):1071-1078. Epub 2016 Jun 2.

PMID:
27255393
40.

Preoperative Nutritional Assessment by Controlling Nutritional Status (CONUT) is Useful to estimate Postoperative Morbidity After Esophagectomy for Esophageal Cancer.

Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Kurashige J, Sakamoto Y, Miyamoto Y, Ishimoto T, Kosumi K, Tokunaga R, Imamura Y, Ida S, Hiyoshi Y, Watanabe M, Baba H.

World J Surg. 2016 Aug;40(8):1910-7. doi: 10.1007/s00268-016-3549-3.

PMID:
27220507
41.

Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma.

Koga Y, Baba Y, Harada K, Kosumi K, Shigaki H, Kurashige J, Ishimoto T, Iwatsuki M, Miyamoto Y, Sakamoto Y, Yoshida N, Baba H.

Surg Case Rep. 2015 Dec;1(1):105. doi: 10.1186/s40792-015-0108-3. Epub 2015 Oct 15.

42.

Mucinous cystic neoplasm of the pancreas activated during pregnancy.

Kosumi K, Takamori H, Hashimoto D, Tanaka H, Abe S, Nakahara O, Horino K, Baba H.

Surg Case Rep. 2015 Dec;1(1):13. doi: 10.1186/s40792-014-0012-2. Epub 2015 Feb 10.

43.

KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review.

Zhou L, Baba Y, Kitano Y, Miyake K, Zhang X, Yamamura K, Kosumi K, Kaida T, Arima K, Taki K, Higashi T, Imai K, Hashimoto D, Yamashita Y, Chikamoto A, Beppu T, Tan X, Baba H.

Med Oncol. 2016 Apr;33(4):32. doi: 10.1007/s12032-016-0745-9. Epub 2016 Feb 29. Review.

PMID:
26927447
44.

APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.

Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Shigaki H, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.

Med Oncol. 2016 Mar;33(3):26. doi: 10.1007/s12032-016-0739-7. Epub 2016 Feb 15.

PMID:
26880326
45.

The role of microRNA in esophageal squamous cell carcinoma.

Harada K, Baba Y, Ishimoto T, Shigaki H, Kosumi K, Yoshida N, Watanabe M, Baba H.

J Gastroenterol. 2016 Jun;51(6):520-30. doi: 10.1007/s00535-016-1161-9. Epub 2016 Jan 21. Review.

PMID:
26794004
46.

Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.

Izumi D, Yoshida N, Watanabe M, Shiraishi S, Ishimoto T, Kosumi K, Tokunaga R, Taki K, Higashi T, Harada K, Miyata T, Ida S, Imamura Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yamashita Y, Baba H.

J Gastroenterol. 2016 Aug;51(8):788-95. doi: 10.1007/s00535-015-1150-4. Epub 2015 Dec 15.

PMID:
26671045
47.

Perioperative Blood Transfusion, Age at Surgery, and Prognosis in a Database of 526 Upper Gastrointestinal Cancers.

Kosumi K, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H.

Dig Surg. 2015;32(6):445-53. doi: 10.1159/000433609. Epub 2015 Oct 20.

PMID:
26550999
48.

The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer.

Tokunaga R, Sakamoto Y, Nakagawa S, Miyake K, Izumi D, Kosumi K, Taki K, Higashi T, Imamura Y, Ishimoto T, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.

Ann Surg Oncol. 2016 Feb;23(2):678-85. doi: 10.1245/s10434-015-4879-3. Epub 2015 Sep 28.

PMID:
26416711
49.

Duration of Smoking Cessation and Postoperative Morbidity After Esophagectomy for Esophageal Cancer: How Long Should Patients Stop Smoking Before Surgery?

Yoshida N, Baba Y, Hiyoshi Y, Shigaki H, Kurashige J, Sakamoto Y, Miyamoto Y, Iwatsuki M, Ishimoto T, Kosumi K, Sugihara H, Harada K, Tokunaga R, Izumi D, Watanabe M, Baba H.

World J Surg. 2016 Jan;40(1):142-7. doi: 10.1007/s00268-015-3236-9.

PMID:
26330238
50.

Prognostic Impact of Visceral Fat Amount and Branched-Chain Amino Acids (BCAA) in Hepatocellular Carcinoma.

Higashi T, Hayashi H, Kaida T, Arima K, Takeyama H, Taki K, Izumi D, Tokunaga R, Kosumi K, Nakagawa S, Okabe H, Imai K, Nitta H, Hashimoto D, Chikamoto A, Beppu T, Baba H.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1041-7. doi: 10.1245/s10434-015-4796-5. Epub 2015 Aug 25.

PMID:
26305023

Supplemental Content

Loading ...
Support Center